                         SEQUENCE LISTING

<110>  Merck Sharp & Dohme Corp.
       Burgey, Christopher S.
       Fritzen, Jeffrey F., Jr.
       Balsells, Jaume
       Patel, Mehul

 
<120>  PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

<130>  23744

<150>  61/973,689
<151>  April 1, 2014

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Chemically synthesized

<400>  1
ttgaaatgac tgcggtacgg c                                                 21


<210>  2
<211>  501
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Chemically synthesized

<400>  2
gagguucagg ugguuuccac cgcaacacaa uccuuccugg cgaccugcgu caacggcgug       60

uguuggaccg uuuaccaugg ugcuggcuca aagaccuuag ccggcccaaa ggggccaauc      120

acccagaugu acacuaaugu ggaccaggac cucgucggcu ggcaggcgcc ccccggggcg      180

cguuccuuga caccaugcac cuguggcagc ucagaccuuu acuuggucac gagacaugcu      240

gacgucauuc cggugcgccg gcggggcgac aguaggggga gccugcucuc ccccaggccu      300

gucuccuacu ugaagggcuc uucggguggu ccacugcucu gcccuucggg gcacgcugug      360

ggcaucuucc gggcugccgu augcacccgg gggguugcga aggcggugga cuuugugccc      420

guagagucca uggaaacuac uaugcggucu ccggucuuca cggacaacuc aucccccccg      480

gccguaccgc agucauuuca a                                                501


